[New medical treatments for polycystic ovary syndrome].
Polycystic ovary syndrome (PCO) is a polygenic disease worsened by obesity and environmental factors. PCO is characterized by chronic menstrual irregularity and hypofertility and metabolic disorders. Routine care includes appropriate diet, exercise and annual check-up to search for high blood pressure. Laboratory tests should include a lipid profile and fasting serum glucose. Insulin sensitizing drugs improve the metabolic pattern, induce ovulation and increase pregnancy rate. Here, we review the different therapeutic options for these patients.
Laboureau-Soares Barbosa
S
S
Unité d'Endocrinologie, Diabétologie et Maladies Métaboliques, CHT Mamao, BP 1640, 98713 Papeete, Tahiti, Polynésie française. Sandrine.soares@cht.pf
Rodien
P
P
Rachédi
F
F
Rohmer
V
V
D001786:Blood Glucose / Q000378:metabolism; D003920:Diabetes Mellitus / Q000517:prevention & control; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000628:therapy*; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D050356:Lipid Metabolism; D008597:Menstrual Cycle / Q000502:physiology*; D009765:Obesity / Q000517:prevention & control; D010062:Ovulation Induction / Q000379:methods; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000503:physiopathology* / Q000628:therapy*; D011247:Pregnancy; D018873:Pregnancy Rate
D001786:Blood Glucose; D007328:Insulin